BillebeauGVodovarNSadouneMet al.Effects of a cardiac rehabilitation programme on plasma cardiac biomarkers in patients with chronic heart failure. Eur J Prev Cardiol2017; 24: 1127–1135.
2.
WarburtonDENicolCWBredinSS. Health benefits of physical activity: The evidence. CMAJ2006; 174: 801–809.
3.
BijnenFCCaspersenCJMosterdWL. Physical inactivity as a risk factor for coronary heart disease: A WHO and International Society and Federation of Cardiology position statement. Bull World Health Organ1994; 72: 1–4.
4.
Masterson CreberRMLeeCSMarguliesKet al.Identifying biomarker patterns and predictors of inflammation and myocardial stress. J Card Fail2015; 21: 439–445.
5.
PiñaILApsteinCSBaladyGJet al.Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation2003; 107: 1210–1225.
6.
O’ConnorCMWhellanDJLeeKLet al.Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA2009; 301: 1439–1450.
7.
PonikowskiPVoorsAAAnkerSDet al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail2016; 18: 891–975.
8.
AhmadTFiuzatMMarkDBet al.The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. Am Heart J2014; 167: 193–202.
9.
PassinoCSeverinoSPolettiRet al.Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol2006; 47: 1835–1839.
10.
Fernandes-SilvaMMGuimarãesGVRigaudVOet al.Inflammatory biomarkers and effect of exercise on functional capacity in patients with heart failure: Insights from a randomized clinical trial. Eur J Prev Cardiol2017; 24: 808–817.
11.
MeijersWCvan der VeldeARMuller KoboldACet al.Variability of biomarkers in patients with chronic heart failure and healthy controls. Eur J Heart Fail2017; 19: 357–365.
